SCHEMBL15937289

SCHEMBL15937289

CC1(C)c2ccccc2N2c3ccccc3C(C)(C)c3cc(-c4cc5c6c(c4)C(C)(C)c4cc(-c7cccc8c7oc7ccccc78)ccc4N6c4ccc(-c6cccc7c6oc6ccccc67)cc4C5(C)C)cc1c32

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.47
PRKDC P78527 5/20 0.41
GGPS1 O95749 1/20 0.37
PTGES2 Q9H7Z7 1/20 0.35
PRMT5 O14744 1/20 0.33
WDR77 Q9BQA1 1/20 0.33
ATM Q13315 1/20 0.33
MEN1 O00255 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32
KDM4E B2RXH2 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
PIK3CD O00329 1/20 0.31
PIK3CB P42338 1/20 0.31
AVPR1A P37288 1/20 0.31
PGR P06401 1/20 0.30
HDAC8 Q9BY41 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15937411 0.97 ALOX5 (0.50) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL15937364 0.93 ALOX5 (0.46) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL13558177 0.89 ALOX5 (0.47) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL18102019 0.89 ALOX5 (0.47) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL13557576 0.88 ALOX5 (0.46) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL13827245 0.87 ALOX5 (0.46) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL13557647 0.87 ALOX5 (0.46) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL13557572 0.87 ALOX5 (0.44) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL17206576 0.86 ALOX5 (0.45) ALOX5PRKDCGGPS1PTGES2PRMT5
SCHEMBL15937270 0.86 ALOX5 (0.41) ALOX5PRKDCGGPS1PTGES2PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160126476-A1 NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE LMS CO., LTD. (KR) 2016-05-05 US disclosed
US-20160126476-A1 NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE LMS CO., LTD. (KR) 2016-05-05 US disclosed
WO-2014119895-A1 NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE 주식회사 엘엠에스 (KR) 2014-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160126476-A1 NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE ELAVL1, SUN2, PER2 ALOX5 640/4885PRKDC 4097/4885GGPS1 142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.